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k Fifty years have elapsed since the discovery of
insulin; however, pregnancy is still far from
being sufficiently safe in diabetic women. The
most convincing proof is given by the high
perinatal mortality ranging from 10 to 15% in
specialized departments [16], which would be
even higher if therapeutic abortion was not
performed in numerous cases of severe maternal
disease [3, 11, 23], On the other hand, äs far äs the
mother is concerned, insulin therapy has
deeply changed the prognosis of pregnant
diabetic patients compared with the preinsulin
era. However, severe complications such äs
toxemia, urinary tract infections, aggravation of
vascular diseases and so forth contribute to
maintain the death rate at about 1% [16, 23],
1. The problem of metabolic balance
In an extensive review of the problem it has
already been emphasized, many years ago [10],
that unfavourable development of pregnancy
and high perinatal mortality are associated
specially with pregnant women lacking a
good metabolic balance. These findings were
subsequently confirmed [16, 23] so that one may
wonder whether in cases, considered to have been
compensated for but still showing a high peri-
natal mortality rate, an actual optimal compen-
sation had been obtained or whether its further
improvement might have ameliorated fetal prog-
nosis. As a matter of fact, the treatment of
pregnant or non-pregnant diabetic patients is
carried out everywhere by regulating the in-
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sulin dosage on the basis of glycemia and
glycosuria. The difficulties found in establishing
the degree of metabolic compensation by means
of these indices caused a considerable discre-
pancy of opinion äs to the optimal values for the
best therapeutical approach [6, 16, 19, 23, 35,
37]. On the other hand, it may be debatable
whether such a criterion represents an "optimum"
for the feto-placental unit in considering that
the features of newborns of diabetic mothers
frequently appear even in newborns of pre-
diabetic mothers, where blood sugar levels
show little or no alteration; interesting results
were obtained by insulin therapy in these cases
[14,22,25,41].
On the basis of the aforesaid considerations we
began our investigations for a stricter control of
diabetes mellitus in pregnancy in 1963. There-
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forc, a new posologic criterion was adoptcd to thc clinical Symptom; thcrcaftcr, thc morning
control diabetes in pregnancy and, moreover, to dose of insulin is decreascd by five units; in this
avoid the possible over- and under-dosage of way the maximal tolerated dosc of this ad-
insulin [24, 25, 26, 27]. It will bc illustrated below ministration is established. The same procc-
dure is applied in finding out the mid-day and
evcning dosages until the maximal toleratcd dose
is established.
Thercfore, the total amount of insulin varies
from one pr gnant paticnt to another; how-
ever, it is regulated according to an identical
dinical indcx> onc which occurs dso in hcalthy
subjccts aftcr admjnistration of a smau dosc of
togethcr with thc obtaincd rcsults.
2. Schemc of therapy
This schcmc consists of progressively increasing
amounts of insulin administered within 24 hours
untii the maximal toleratcd dose is reached, the
tolerance limit being indicatcd by the appearance
of thc minor Symptoms preceding the onset of
hypoglycemia: perspiration is thc most evident iangcrhansian hormone [27J.
and constant Symptom among them*. The
 On admission to our department the patient
procedure for the administration of insulin is
 choses hcr own diet without particular rcstric-
summarized in Tab. I; threc black dots on thc
 tion$i Thjg dict is thcn rigorou8ly obscrvcd, care
first linc indicate the insulin dose takcn by thc
 bdng takcn as to calorjc CC]uivaiencc in the case
paticnt bcforc hospitalization (corrcsponding to
 of quaiitativc modifications.
0 I.U., if the pregnant subject has not yct been
 Later on> patients are discharged and checked
given insulin). weekly in the out-patient department; during
Later on, each of the threc daily amounts is periodicalhospitalizationsinourclepartmentthe
increased by 5 I.U. of fast-acting insulin
 insulin dose is adjustccl to changes required
until the paticnts fccls the first Symptoms of
 durlng pregnftncy according to our criterion
hypoglycemia (perspiration). In the hypothetical r g jg 231
case of the scheme, this occurs after having
administered the morning insulin dosc but it is 3· Results
quickly relieved by administering some lurnps 3.1 Dict
of sugar or, if nccessary, intravcnous glucose Our criterion made it possible to avoid numerous
infusions. The insulin dosage is maintained un- difficultics expcricnced in dictary prcscriptions
changed on the following day in order to confirm for diabctic paticnts as well as troubles occurring
* Thie"mcAod of administcring insulin can bc dcfmcd in pregnancy because of frequcnt food intoler-
also as pre-hypoglycemic insulin therapy, PHIT. ance.
Tab. I. Schemc of followed Insulin therapy; s. == swcating; m. t. d. =- maximnl toleratcd dosc.
Day 08.00 a. m. 12.00 07.00 p. in.
I
n
III
IV
v
VI
VII
vin
IX
X
XI
XII
XIII
XIV
o
Φ+5 I.U.
•+5 I.U.
•+10 I.U.
• -HOI.U.
• H-15I. U. s.
•+15I.U.S.
•+10I. U. m. t.d.
• H-10I.U.
•+10I.U.
•+10I.U.
•+10 I.U.
•+10I.U.
•+10 I.U.
e
•+5 I.U.
•+5 I.U.
•+10 I.U.
•+10I.U.
•+15 I.U.
•+15 I.U.
•+20 I.U.
•+20 I.U.
• +25 I.U.
• +25I.U.
• +301. U.s.
•+30 I.U. s.
•+25I. U. m. t. d.
O
O+5 I.U.
0+5 I.U.
β +10 I.U.
O+101. U.
O+151.U.
©+15 I.U.
O +201. U.s.
O +201. U. s.
•+15I. U. m. t. d.
β +15 I.U.
• + 15 I.U.
β +15 I.U.
•+15 I.U.
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After some days treatment it was necessary, in
many cases, to reduce the amount of calories at
the patient's request.
In addition, the influence of such a criterion
concerning the quantitative and qualitative
composition of single diets was verified by
means of further control examinations. The
average calorie amount administered in 24 hours
was about 1,900 calories; in most cases (Tab. II)
the calories were kept within the limits of ±20%
s compared with the individual requirement
[34] corresponding to the needs of a resting and
moderately working subject.
As for the calorie percentage on the average the
diet was composed (Tab. III) of 15.5% of
protides, 53.2% of glucides and 31.3 of lipids,
,with oscillations of ±10% in the majority of
cases.
3.2 Insulin requirement
In the course of pregnancy a progressive in-
crease in insulin requirement was aJways
observed. At term of gestation this increase
reached about 50 units of insulin daily over and
above the maximal dose tolerated in the first
trimester of pregnancy (Fig. 1).
Immediately after delivery it was always
necessary to reduce the insulin dosage; in
particular, insulin had to be discontinued in the
Tab. II. Distribution of cases reported according to the
difference in percentage between. calories supplied with
diet and daily calorie requirement s calculated individually
according to VANZETTI and GATTI'S nomogram [34],
Difference
between calories
of diet and ideal
requirement ±10% ±20% ±300/0
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Fig. 1. Increase of insulin requirement during pregnancy.
Tab. IV. Distribution of case report according to WHITE'S
classification [38] and by trimester in which compensation
was achieved.
Class
A
B
C
D
F
I
4
12
4
4
4
Trimester
II
13
20
8
3
1
III
31
16
7
3
6
Total
48
48
19
10
11
28 45 63 136
Cases 64.5% 26.70/0 8.8%
majority of cases belonging to WHITE'S class A
[38] (Tab. IV). No pregnant patient was found
to be insulin resistant according to WHO's
definition [40],
3.3 Case report
It includes 136 pregnant women treated ac-
cording to the above-mentioned scheme. Tab. IV
subdivides the patients according to the se-
verity of diabetes [38] and the trimester of be-
ginning treatment. WHITE'S class A includes
pregnant women with pregnancy diabetes and
with latent diabetes, i. e. with reduced tolerance
to glucose (capillar blood s gar level superior to
140% 120min after an oral load of 50g of
glucose).
Tab. III Average composition o£ diet and percentage of cases with differences o£ ± 10%, ± 20%, ± 30% s com-
pared with the mean values of each component.
Average
percentage
composition of diet
Percentage of
cases with differences
of±10%
Percentage of
cases with differences
of±20%
Percentage of
cases with djfferences
of±30%
Protides
Glucides
Lipids
15.53%
53.17%
31.30%
71.1%
71-1%
53.30/0
24.4%
26.7%
37.80/0
4.50/0
• 2.20/0
8.90/0
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3.4 Time of delivery
Pregnant women were controlled by determining
urinary estriol [5] and in the last five years by
amnioscopy [28]. Delivery was never anti-
cipated by inducing labor or performing a
Caesarean section; delivery occurred beyond the
37 th week of pregnancy in 89% of the cases and
beyond the 40th week in 13% (Tab. V).
3.5 Type of delivery
Vaginal delivery in 75% of the cases (Tab. VI)
with application of vacuum extractor in 8.8%.
In 25% of the cases Caesarean sections were
indicated, when labor had started spontaneously;
26.4% of those were multiparae already pre-
viously submitted to Caesarean section.
In the last three years fetal conditions during
labor were controlled by micro blood sampling
[29, 30] and by continuous recording of fetal
heart rate [15], Determinations of pH values in
fetuses (Fig. 2) evidence only a moderate degree
of acidosis of maternal origin [1] äs shown by
comparing the metabolic component of the
acid-base balance of the mother with that of the
fetus [29, 31]. Marked acidosis occurred during
the second stage of labor only in two cases;
these were complicated by a true knot and by
premature Separation of the placenta after hyper-
Tab. V. Distribution of cases reported according to time
of delivery.
7.50
7.40
_· 7.30
u
o
^7.20
7.10
7.00
-B-
l J_ l l
Weeks of
amenorrhea
34
35
36
37
38
39
40
41
42
No. of cases
1
2
4
8
27
26
50
7
U
%
0.7
1.5
2.9
5.9
19.9
19.1
36.8
5.1
8.1
Cervix Cervix Cervix II Umb. Umb.
1-2 cm 3-4 cm 5-10 cm Stage V. A.
Fig. 2. Actual pH of fetus during labor (number of
cases: 44; number of blood samples: 120). Mean values
± 2 sd (continuous lines) and 95% confidence limits of
the mean (shaded area).
tension of pregnancy due to adrenal adenoma
respectively.
3.6 Weight of newborns
The curve of distribution of weight in newborns
(Tab. VII) shows that in 81% of the cases the
weight ranged from 2,500 to 4,000 g and ex-
ceeded 4,000 g only in 7.2% of the infants.
Babies weighing less than 2,500 g are those born
within the 37th week of pregnancy.
3.7 Perinatal mortality and malformations
in multiparae
Perinatal mortality among patients belonging to
WHITE'S class A and WHITE'S classes B, C, D and
F was in previous pregnancies 26.7% and 37.3%
respectively, whereas no case of fetal-neonatal
death was observed during these pregnancies
(Tab. VIII).
Tab. VIII. Distribution weight at birth.
Weight (g) No
Tab. VI. Classification of cases according to the mode of
delivery.
Spontaneous
Vacuum extractor
Caesarean section
66.2% N
8.8% ,
\ I-J £ f\(\// 75.0%
25.0%
1,500—2,000
2,001—2,500
2,501—3,000
3,001—3,500
3,501—4,000
4,001—4,500
4,501—5,000
5,001—5,500
4
12
32
55
25
7
1
2
2.9
8.7
23.2
39.9
18.1
5.1
0.7
1,4
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Tab. VIII. Comparison of perinatal mortality and incidence of malformations between present and previous pregnancies
in multiparae of our series distributed according to WHITE'S classification [38].
Class
A J
i
B+C+D+FJ
Sum:
:
Alive not malf.
Alive malformed
Dead not malf.
Dead malformed
Sum:
Alive not malf.
Alive malformed
Dead not malf.
Dead malformed
Number of
Previous pregnancies
45
33 (73.3%)
0
9 (20.0%)
3 (6.7%)
118
71 (60.2%)
3 (2.5%)
37 (31.4%)
7 (5.9%)
newborns
Present pregnancy
24
24
0
0
0
59
57 (96.6%)
2 (3.4%)
0
0
Tab. IX. Total perinatal mortality and its distribution (in brackets the number of deaths) according to trimester of be-
ginning of treatment and to WHITE'S classification [38].
Class
A
B
C
D
F
I
4(0)
12(0)
4(0)
4(0)
4(0)
28(0)
Trimester
II
13(1)
20(0)
8(0)
3(0)
1(0)
45(1)
32(1)
17(0)
7(0)
3(0)
6(2)
65(3)
49(2)
49(0)
19(0)
10(0)
11 (2)
138 (4)
Total
= 2.9%
As regards the incidence o£ malformation a case
of syndactylia with partial lack of both first
phalanges in the right hand and a case of Stenosis
of the pulmonary artery occurred in multiparae
while in previous pregnancies the total incidence
of malformations incompatible with life
teached about 6%; the malformations com-
patible with life occurred in 2.5% of newborns
of mothers belonging to WHITE'S classes B, C, D
and F.
3.8 Perinatal mortality*
Only four cases of fetal and neonatal death
occurred among our patients in this series,
giving a perinatal mortality of 2.9%.
If the cases are classified according to the tri-
mester in which pregnant patients were com-
pensated following PHIT (Tab. IX) it can be
seen, that no case of perinatal death occurred in
patients treated from the first trimester; only one
* Perinatal mortality was calculated including the neo-
natal period until the time of discharge of infants from
Hospital.
case was observed ämöng patients treated from
the second trimester and, perinatal mortality
actually increased in the group of patients treated
only since the third trimester.
The distribution of mortality was shown to be
exclusively within in the classes A and F of
WHITE'S classification.
From the analysis of the four cases of fetal-
neonatal death it should be noted that äs regards
the patient belonging to WHITE'S class A and
treated since the second trimester, the intrauterine
death was due to prolapse of the cörd after pre-
mature rupture of the membranes at the 35th
week of pregnancy.
In two other cases, belonging to WHITE'S class
A and F, the cause of intrauterine fetal death
could be attributed to toxemia, whereas in the
last case the newborn died on the 8th day because
of neonatal infection from herpes virus.
3.9 Therapeutic abortion
Therapeutic abortion was never performed even
when patients were sent to our department with
J. Perinat. Med. l (1973)
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the indication for this Operation because of risk. It should be noted that 30% of patients
severe vascular complications. belong to WHITE'S classes C, D and F, i. e.
those offering minor probabilities of survial for
3.10 Toxemia and fetal malformations
 fetuses Moreover, pregnant diabetic patients
Toxemia was observed äs a complication in treated within the 26th week of pregnancy show
eight cases (5.8%), four of which belonging to
 a perinatal mortality of 1.73% because of a case
WHITE'S class F and four subdivided among
 of prolapse of the cord in the 35th week of
WHITE'S remaining classes. Only in two cases pregnancy.
belonging to WHITE'S class A and F respectively,
did toxemia set in with such serious Symptoms 4.2 Results in fetal weight
äs to be defined "severe" [23]. The considerable decrease in perinatal mor-
Malformations occurred in 2.9% of cases. tality and in fetal macrosomia äs evidenced by
None of them was incompatible with life the cases we reported confirms their direct
and, to be precise, consisted of a supernumerary connection with the degree of maternal
finger of the right hand and a partial defect of metabolic compensation during the pregnancy
ossification of the frontal bone. äs supported by various authors [7,10,16,19, 23].
Moreover according to our data, the incidence
4. Discussion
 Of macrosomia seems to be further reduced
The above-mentioned results show that the whenever the mother's insulin deficiency is com-
condition of pregnant diabetic patients — no pensated for in early pregnancy. As a matter of
matter how serious their metabolic disorder is — fact, none of the 73 pregnant women treated
can be brought to a normal state äs far äs the since the first two trimesters gave birth to
development and result of pregnancy are con- infants weighing more than 4,500 g and only
cerned. two (2.7%) between 4,000 and 4,500 g; on the
In this respect, two elements proved to be in- contrary, 65 patients treated only since the third
dispensable. The first one is the administration trimester gave birth to 5 infants (7.7%) weighing
of insulin according to a criterion which assures a 4,000—4,500 g and to 3 (4.6%) weighing more
constant metabolic compensation during preg- than 4,500 g.
nancy; that means not only a blood sugar
balance but also an insulin balance, where the 4·3 Incidence of congenital malformations
further administration of insulin would have the The incidence of congenital malformations of
same effect äs on a non-diabetic subject. The fetuses is reduced in our case report and corre-
second one is the intensive care of patients sponds practically to that reported for normal
frequently supervised by a specialist. In fact, pregnant women [16, 23]; this is undoubtedly an
we never had to apply the measures generally extremely interesting result because the high
used in the treatment of pregnancies of diabetics, percentage of fetal malformations, especially in
namely therapeutic abortion in cases with severe the case of vascular complications [20], is one of
vascular complications, hormonal prophylaxis the major problems for pregnant diabetic pa-
and Interruption of pregnancy at the 36—37th tients. Moreover we have to bear in mind the
week by induction of labor or Caesarean section. teratogenic effect of high doses of insulin in
Likewise no preventive care was taken in order to animals [4, 33], the frequent findings of fetal
prevent conception, such äs the use of contra- malformations in pregnant women undergoing
ceptives or surgical Sterilisation. insulin shock therapy because of mental dis-
orders at the beginning of pregnancy [17, 18] and
4.1 Results in terms of perinatal mortality the high incidence (34.2%) of hypoglycemia in
Perinatal mortality, which represents the index the Ist trimester shown by pregnant women
of pre-eminent interest in diabetic patients, is in who gave birth to malformed fetuses [12]. It is
the cases we reported reduced to values which therefore necessary to adopt a scheme for an
can also be accepted for pregnancies not at insulin treatment assuring not only an excellent
J. Perinat. Med. l (1973)
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metabolic compensation but also the prevention tality in pregnant women affected with this
of harmful hypoglycemic accidents in preg- type of diabetes. In fact', the perinatal mortality
nant diabetic patients. of 24 multiparae belonging to WHITE'S class A
reached 25% in former pregnancies whereas no
4.4 Importance of severity of maternal dis-
 case of death Occurred in these pregnancies and
o*der the weight of newborns never exceeded 4,000 g.
The outstanding importance of mother's meta- Authors carrying out insulin therapy in pregnant
bolic compensation äs to the result of pregnancyis women with latent diabetes [14, 22, 41] cannot
confirmed also by the lack of interrelation that use blood and urinary sugar levels äs referrant
we were able to observe between fetal risk and parameters. Therefore, they rely upon their own
severity of maternal disorder; äs a matter of precautionary criteria and establish a priori in all
fact, the incidence of perinatal mortality äs well these cases the same insulin dosage, which
äs of all manifestations indicated äs diabetic obviously proves unable to achieve uniform and
fetopathy do not increase from WHITE'S class excellent metabolic balance in all instances. These
A to F äs reported in literature [16, 23]. inconveniences and troubles can be overcome by
On the contrary, the manifestation of late toxemia applying our scheme which is suitable also for
seems to bring a considerable increase in fetal pregnant women with latent diabetes where it
risk äs mentioned above [19, 23]; in point of proves to be of great value in setting up a clinical
fact, two of the four lethal cases occurred in index for blood and urinary sugar levels in
pregnant women with severe signs of toxemia monitoring insulin therapy.
(l case of WHITE'S class A and another of WHITE'S Sweating appears to be the earliest and most steady
class F). Symptom when in non-diabetic subjects the nor-
In pregnant women affected with extremely mal balance is modified by fasting or by ad-
severe diabetes (WHITE'S class D and above all ministering small doses of insulin. Severe hypo-
WHITE'S class F) the problem of clinical ap- glycemic crises can be avoided with certainty by
proach which proves difficult because of the applying such a scheme causing sweating because
high perinatal mortality is furthermore compll·· theamount of insulin is increased by-only 5 L U. in
cated by a progressive worsening of vascular each of three injections.
disease äs frequently observed in the course of Likewise, after discharge from our department
pregnancy [13, 21, 23, 39] so that therapeutic no cases of hypoglycemic coma — usually
abortion may be often considered necessary. In not rare in diabetic pregnancy —^ were observed,
our experience we never found a tendency to because the final dose (maximal tolerated dose)
such a worsening of retinopathy of patients is established by reducing the dose causing
belonging to WHITE'S class D and F [36]; there- sweating by 15 L U. of insulin (5 for each series).
after, there is evidence of a favourable develop- Also the prevention of acidosis or diabetic
ment of pregnancy for both mother and fetus, and precoma seems in our cases an important result
the practice of therapeutic abortion in these cases if one considers their well-known influence in
has to be accepted with greater reservations worsening the prognosis of the fetus [23]. The
[16, 23]. 24-hour blood sugar levels (at 4.00, 8.00, 12.00,
16.00, 20.00, 24.00 hours) after having reached
4.5 Treatment of latent diabetes
 the balance showed values within normal limits.
The group of pregnant women belonging to
WHITE'S class A commands particular attention.
There is in the literature a divergence of opinion 4'5 Antenatal care
about the treatment of latent diabetes in Therefore, a program of intensive care with
pregnancy [16, 23]. As previously observed by weekly follow-ups in the out-patient depart-
some authors [14> 22, 41], and according also to ment and, if necessary, short periods of hospi-
our results, the insulin treatment can decrease talization proved to be indispensable for ad-
the neonatal weight and the perinatal mor- justing the maximal tolerated dose to the well-
J. Perinat. Med. l (1973)
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known incrcasc in insulin requirement during
pregnancy. At any rate, we were ablc to observe
cases requiring a frequent increase in maximal
tolerated dose up to delivery äs contrasted to
other ones in which the dose has to be kept
unchanged over much longer periods of time.
As for the diet, the idea of choosing the diet
herseif had a positive psychological effect on
the patient, but in most cases the free diet cor-
responded in the quantitative and qualitative
composition to the theoretical requirements
(Tabs. II to III).
4.7 Delivery time of diabetics
At the present, the opinions reported in the
literature äs to the most convenient time of
delivery for diabetic pregnant patients are not
standardized. The induction of delivery at the
36—37 th week of gestation, äs recommended by
most authors [10, 11, 16, 23, 38] because of the
high perinatal mortality in the last month, is in the
opinion of others [2, 19, 32] not necessary for
pregnant patients at term who have been well
regulated and have had no complications of
pregnancy.
In our series delivery was never induced but
started spontaneously and in some cases
beyond the presumed term. In the course of
labor only slight diminution of pH values due to
the passage of fixed acids from mother to fetus
has to be pointed out [29]; this acidosis, however,
never caused severe problems at birth.
Although not forming part of the purpose of
this work, we cannot ignore in our conclusions
the problems of the pediatrician attending the
newborn of diabetic mother: the results of a
previous series of own cases [9] did not sub-
stantially change, i. e. the particular clinical and
humoral phenomenology of the newborn of
diabetic women occurred in a very small per-
centage of cases and, moreover, in such a way
äs to be easy to control.
4.8 Conclusion
Our results obtained since 1963 in the treatment
of pregnant diabetic patients have been re-
peatedly reported [25, 26, 27]. In consideration
of the paramount importance of results äs to the
appraisal of therapy, their constant positive
outcome strongly suggest that the theoretical
premises of PHIT have been confirmed, i. e.
the necessity of achieving in pregnant diabetic
patients a metabolic compensation so that both
administered and endogenous insulin may cor-
respond to the requirements of the organism.
The easy handling together with the ease of
avoiding accidents due to under- or over-
dosage of insulin makes it possible to carry out
intensive care of pregnant diabetic women even
where no specialized centres are available.
Summary
According to the literature, at an appraisal "a posteriori"
fetal risk in pregnant diabetic patients appears to be
always reduced by a good control of maternal disorder.
However, the various authors are of quite different opinions
äs to the value to be attributed to the indices of carbohy-
drate metabolism in insulin-compensated pregnant diabetic
patients so that it seems difficult "a priori", i. e. during
pregnancy, to guarantee a successful treatment for the
fetus. On the other hand, the problem becomes compli-
cated if one also considers the high risk for fetuses of
pregnant women affected with latent diabetes.
Therefore, since 1963 a particular therapeutical criterion
has been adopted: fast-acting insulin was administered in
three daily injections at continuously increasing doses.
When early hypoglycemic troubles (sweating, feeling of
hunger and so forth) set in, the excess dose was reduced
(Tab. I).
At the admission to our department the diet was chosen by
the patient without particular restrictions and then rig-
orously observed with regard to caloric equivalence in the
case of qualitative modifications. In most cases that diet
corresponded quantitatively and qualitatively to the
theoretical requirements of the pregnant patients (Tabs.
II to ).
Weekly control examinations and eventual short periods of
hospitalizatiön proved to be necessary in order to maintain
a balance between the maximal tolerated dose, established
during the first hospitalization, and the continuous increase
in insulin requirement during pregnancy (Fig. 1);
the spontaneous onset of labor was always awaited
(Tab. V) and the estriol in urine was systematically
determined; amnioscopy has been performed since 1967.
Vaginal delivery was observed in 75% out of 136 cases
(Tab. VI), 88 belonging to WHITE'S classes B, C, D, F
(Tab. IV). Determinations of pH values in fetuses (Fig. 2)
evidenced only a moderate degree of acidosis of maternal
origin. Perinatal mortality amounted to 2.9% (Tab. IX),
the incidence of macrosomia (> 4,000 g) was 7.2%
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(Tab. VII), toxemia occurred in 5.8% of the cases, and requirements and it can be jrplized without specialized
__^ _ . _ __^. _ *.* .__ _ -.1 >. -— i.?!- i - __ ,J^1_ 1 £ <!«. O OO/ s~A«t4-A«O / ^4·<»/· 4· *· ^»/ » /i1e/~v r»*» *·» /^ ir\ T\iff*£m&nt' *malformations, always compatible with life, in 2.9%.
The results show that the fetal risk in pregnant diabetic
patient can be deeply reduced maintaining a constant
insulin balance. The adopted scheme seems to fulfil these
centers. Moreover, it can also be applied to pregnant women
with latent diabetes where, according to the experience of
various authors, insulin therapy can reduce fetal risk
(Tabs, Vni to IX).
Keywords: Diabetes, prediabetes, pregnancy, perinatal mortality, Insulin,
formations.
^ prehypoglycemia, toxemia, mal-
Zusammenfassung
Die Intensiv-Überwachung der schwangeren Diabeti-
kerin (136 Fälle): Ein neues therapeutisches Schema für
die beste Kontrolle der mütterlichen Krankheit.
Nach Literaturangaben nimmt das fetale Risiko bei der
diabetischen Schwangeren mit der Güte der Kontrolle
der mütterlichen Krankheit ab. Allerdings gibt es
Meinungsunterschiede unter den Autoren über die Ein-
stellung der Parameter des Kohlenhydra t-Stoffwechsels bei
der diabetischen Schwangeren, die zur optimalen Kom-
pensation erreicht werden müssen. Es ist also schwierig
während der Schwangerschaft, eine erfolgreiche Behand-
lung des Feten zu garantieren. Außerdem wird das Problem
komplizierter, wenn man bedenkt, daß auch für Feten von
Schwangeren mit einem latentem Diabetes ein hohes
Risiko besteht.
1963 haben wir eine n„ue Behandlungsmethode vorge-
schlagen. Alt-Insulin wird mit drei täglichen Spritzen in
um 5 E. steigenden Dosen gegeben; wenn die ersten
Zeichen der Hypoglykämie auftreten (leichtes Schwitzen,
Hunger usw.) wird die Insulingabe um 5 Einheiten ver-
kleinert, so wird die tolerierte Maximaldosis festgestellt
(Tab. I).
Die Diät, die die Schwangeren in der Klinik erhalten
haben, ist ohne besondere Einschränkungen. Die Kalorien
bleiben bei qualitativen Änderungen gleich. In den meisten
Fällen entspricht diese Diät sowohl quantitativ als auch
qualitativ dem theoretischen Bedarf der Schwangeren
(Tab. , HI).
Bei wöchentlichen Kontrollen und wiederholten Auf-
nahmen in die Klinik wurde die Insulindosis an die
Änderungen des Insulinbedarfs angepaßt (Abb. 1);
nie haben wir die Schwangerschaft vorzeitig beendet
(Tab. V), und die Patientinnen wurden durch systematische
Messungen der Östriolausscheidung und seit 1967 auch
amnioskopisch überwacht.
Von 136 Fällen gehörten 88 zu den Klassen B, C, D und F
nach WHITE (Tab. IV), bei ungefähr 75% der Schwan-
geren wurde eine vaginale Entbindung durchgeführt
(Tab. VI). Die Bestimmung der fetalen Blut-pH-Werte
(Abb. 2) zeigte nur eine begrenzte Aziditätssteigerung
mütterlichen Ursprungs. Die perinatale Mortalität
betrug 2.9% (Tab. IX), Makrosomie (> 4000 g) 7.2%
(Tab. VH), Gestose 5.8% der Fälle und die Mißbildungen
(die nicht lebensgefährlich waren) 2.9%.
Diese Resultate zeigen, daß das Risiko der diabetischen
Schwangeren und das Risiko des Feten einer dia-
betischen Schwangeren durch ein konstantes Insulin-
Gleichgewicht beträchtlich gesenkt werden kann.
Dieses Problem wird durch die prähypoglykämische
Insulin-Therapie gelöst, auch in nicht spezialisierten
Zentren. Außerdem kann diese Methode bei Schwangeren
mit latentem Diabetes angewandt werden, bei denen, wie
verschiedene Autoren meinen, die Insulin-Therapie das
fetale Risiko senkt (Tab. VHI, IX).
Schlüsselwörter: Diabetes, Prädiabetes, Schwangerschaft, perinatale Mortalität, Insulin, pH, Prähypoglykämie, Gestose,
Mißbildungen.
Resume
Soins intensifs et risque perinatal chez les femmes
enceintes diabetiques (136 cas): un nouveau Schema
therapeutique pour le meilleur contröle de la maladie
maternelle.
Selon la litterature, le risque foetal apprecie «a posteriori»
chez les diabetiques enceintes semble etre toujours
reduit par un bon contröle du desordre maternel.
Cependant, les differents auteurs ont des opinions tout-ä-
fait differentes sur la valeur a attribuer aux index du
metabolisme des hydrates de carbone chez une diabetique
enceinte equilibree, de teile sorte qu'il semble difficile
«a priori», par exemple pendant la grossesse, d'etre assure
du succes du traitement pour le foetus. Par ailleurs, le pro-
bleme se complique si considere aussi le haut risque
pour les foetus chez les patientes atteintes de diabete latent.
Ainsi, depuis 1963 un critere therapeutique special a ete
adopte: de Pinsuline ordinaire etait administr£e a raison de
trois injections par jour a des doses constamment crois-
santes. Lorsque les premiers troubles 'hypoglycemiques
(sueur, Sensation de faim ou autres) apparaissaient, la dose
etak ^duite (Tab. I).
A Tadmission dans notre Service, le regime etait choisi
par la patiente sans restrictions particu^res et rigoureuse-
ment observe en tenant compte de l'equivalent calorique
J. Perinat. Med. l (1973)
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dans le cas de modifications qualitatives. Dans la plupart
des cas le rogime correspondait a la composition quanti-
tative et qualitative des besoins theoriques chez la femme
enceinte (Tab. II, III).
Des controles hebdomadaires et eventuellement de courtes
poriodes d'hospitalisation se sont av6r6s nocessaires pour
maintenir l'equilibre entre la dose maximale toleroe,
etablie au cours de la premiere hospitalisation, et Paug-
mentation continue du besoin en insuline au cours de la
grossesse (Fig. 1); on a toujours attendu le debut
spontane du travail (Tab. V) et les oestriols urinaires
etaient mesures systomatiquement; on a fait des amnio-
scopies depuis 1967.
On a observe 75% d'accouchements par voie basse sur
136 cas (Tab. VI), 88 appartenaient aux classes B, C, D,
F (Tab. IV). La determination des valeurs du pH chez le
foetus (Fig. 2) a mis seulement en ovidence une acidose
moderne d'otigine maternelle. La mortalite perinatale
a et£ de 2,9% (Tab. IX); l'incidence de la macrosomie
(> 4000g) etait de 7,2% (Tab. VII); une toxemie est
apparue dans 5,8% des cas et des malformations, tou-
jours compatibles avec la vie, dans 2,9% des cas.
Les resultats montrent que le tisque perinatal chez les
femmes enceintes diabetiques peut etre fort reduit
en maintenant un bon equilibre insulinique. Le Schema
adopte semble repondre a ces besoins et il peut etre em-
ployo dans des centres pas specialisos. D'aüleurs il peut
aussi etre appliqud aux femmes enceintes avec diabete latent
chez lesquelles, selon l'experience de diffdrents auteurs,
le traitement par rinsuline pourrait reduire le risque foetal
(Tab. VIII et IX).
Mots-cles: Diabete, p^diabete, grossesse, mortalito perinatale, insulinotl^rapie, pH, prehypoglycemie, toxemie, mal-
formations.
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